Heron Bay Capital Management Purchases New Position in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL)

Heron Bay Capital Management purchased a new stake in shares of Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 31,766 shares of the company’s stock, valued at approximately $235,000.

Separately, Rowlandmiller & PARTNERS.ADV purchased a new stake in Cryo-Cell International in the fourth quarter worth about $107,000. Hedge funds and other institutional investors own 10.44% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Maxim Group cut their price objective on shares of Cryo-Cell International from $9.00 to $8.50 and set a “buy” rating on the stock in a report on Tuesday, March 4th.

Cryo-Cell International Stock Performance

Shares of CCEL opened at $6.58 on Friday. The stock has a market capitalization of $53.03 million, a price-to-earnings ratio of -6.21 and a beta of 0.53. Cryo-Cell International, Inc. has a fifty-two week low of $5.75 and a fifty-two week high of $9.50.

Cryo-Cell International Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were paid a $0.25 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.00 annualized dividend and a dividend yield of 15.20%. Cryo-Cell International’s dividend payout ratio is presently -94.34%.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.